首页|甲泼尼龙琥珀酸钠联合肾上腺素治疗过敏性休克患者的效果

甲泼尼龙琥珀酸钠联合肾上腺素治疗过敏性休克患者的效果

扫码查看
目的:观察甲泼尼龙琥珀酸钠联合肾上腺素治疗过敏性休克患者的效果.方法:回顾性分析 2021 年 3 月至 2023 年 3 月该院收治的 80 例过敏性休克患者的临床资料,按照不同治疗方案将其分为研究组(n=40)与对照组(n=40).对照组给予肾上腺素治疗,研究组在对照组基础上联合注射用甲泼尼龙琥珀酸钠治疗,比较两组抢救成功率、抢救成功患者临床症状改善时间、治疗前后血气分析指标[动脉血二氧化碳分压(PaCO2)、动脉血氧分压(PaO2)、血氧饱和度(SpO2)]水平和不良反应发生率.结果:研究组抢救成功率为 95.00%(38/40),高于对照组的 77.50%(31/40),差异有统计学意义(P<0.05);研究组抢救成功患者呼吸困难、胸闷心悸、皮疹、血压下降等临床症状改善时间均短于对照组,差异有统计学意义(P<0.05);治疗1 h后,两组抢救成功患者PaO2、SpO2 水平高于治疗前,且研究组高于对照组,PaCO2 水平均低于治疗前,且研究组低于对照组,差异均有统计学意义(P<0.05);两组抢救成功患者不良反应发生率比较,差异无统计学意义(P>0.05).结论:甲泼尼龙琥珀酸钠联合肾上腺素治疗过敏性休克患者可提高抢救成功率,缩短抢救成功患者临床症状改善时间,改善抢救成功患者血气分析指标水平,效果优于单纯肾上腺素治疗.
Effects of Methylprednisolone sodium succinate combined with Epinephrine in treatment of patients with allergic shock
Objective:To observe effects of Methylprednisolone sodium succinate combined with Epinephrine in treatment of patients with allergic shock.Methods:The clinical data of 80 patients with allergic shock admitted to this hospital from March 2021 to March 2023 were retrospectively analyzed.According to different treatment options,they were divided into study group(n=40)and control group(n=40).The control group was treated with Epinephrine,while the study group was treated with Methylprednisolone sodium succinate for injection on the basis of that of the control group.The rescue success rate,the clinical symptom improvement time of successful rescue patients,the blood gas analysis indexes[arterial partial pressure of carbon dioxide(PaCO2),arterial partial pressure of oxygen(PaO2),blood oxygen saturation(SpO2)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The rescue success rate of the study group was 95.00%(38/40),which was higher than 77.50%(31/40)of the control group,and the difference was statistically significant(P<0.05).The improvement time of clinical symptoms such as dyspnea,chest tightness,palpitation,rash and blood pressure drop in the study group was shorter than that in the control group,and the difference was statistically significant(P<0.05).After 1 h of treatment,the levels of PaO2 and SpO2 in the two groups were higher than those before the treatment,and those in the study group were higher than those in the control group;the PaCO2 level of the two groups of successful rescue patients was lower than that before the treatment,and that in the study group was lower than that in the control group;and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Methylprednisolone sodium succinate combined with Epinephrine in the treatment of the patients with allergic shock can improve the rescue success rate,shorten the clinical symptom improvement time in the patients with successful rescue,and improve the levels of blood gas analysis indexes in the patients with successful rescue.Moreover,it is superior to single Epinephrine treatment.

Methylprednisolone sodium succinateEpinephrineAllergic shockRescue success rateClinical symptomBlood gas analysis indexAdverse reaction

刘岩

展开 >

郑州人民医院北院区急诊科,河南 郑州 450003

甲泼尼龙琥珀酸钠 肾上腺素 过敏性休克 抢救成功率 临床症状 血气分析指标 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(9)
  • 15